Seroba Kernel Funds

Our 'Seroba Kernel Life Sciences Fund II' focuses on innovative opportunities that match market needs, investing on average €5 to €7 million over the life of each investment.  We invest from early-stage to more mature, development-stage companies.

Smaller investments of up to a maximum of €0.5m are also available for start-ups seeking seed funding.  These investments are made from the 'Bank of Ireland MedTech Accelerator Fund', a fund managed by our partner-firm, Kernel Capital, with whom we work closely in evaluating life science opportunities.

If you have a company, or just an idea about how to improve medical care, and you are currently seeking funding to realise its potential, then why not give us a call?